[
Poxel Announces Grant of New Patent in Japan for the Use of Imeglimin in Type-2 Diabetic Patients with Renal Impairment
[og_img]
https://www.investing.com/news/press-releases/poxel-announces-grant-of-new-patent-in-japan-for-the-use-of-imeglimin-in-type2-diabetic-patients-with-renal-impairment-93CH-3956314
Investing.com
Poxel Announces Grant of New Patent in Japan for the Use of Imeglimin in Type-2 Diabetic Patients with Renal Impairment
Related articles